Prefilled Syringes Market by Material (Glass-based and Plastic-based), Design (Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes), Therapeutic (Large Molecules and Small Molecules), and Application (Anap
Description
Prefilled Syringes Market by Material (Glass-based and Plastic-based), Design (Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes), Therapeutic (Large Molecules and Small Molecules), and Application (Anaphylaxis, Rheumatoid Arthritis, Diabetes, and Others (Cancer, Multiple Sclerosis and Others)): Global Opportunity Analysis and Industry Forecast, 2021–2030
The global prefilled syringes market was valued at $5,620.23 million in 2020, and is projected to reach $15,735.49 million by 2030, registering a CAGR of 10.8% from 2021 to 2030.
A prefilled syringe is a syringe filled with a fixed quantity of a therapeutic drug. These are novel devices used for delivering drugs with improved accuracy, affordability, efficacy, convenience, sterility, safety, and accessibility. These features make it more advantageous than traditional methods of drug delivery where glass or metal vials were used to store pharmaceutical drugs. The removal of drug from these vials was prone to contamination and increased the possibility of dosing errors. Therefore, prefilled syringes eliminate the mentioned drawbacks, resulting in increase in their demand.
The growth in home-based healthcare market, increase in adoption of injectable drugs, rise in incidence rate of chronic diseases, and surge in benefits of using prefilled syringes over conventional vials drive the growth of the market. Moreover, technological advancements related to the prefilled syringes contribute toward the growth of the market. However, stringent government regulations, availability of alternative drug-delivery methods, and product recalls are expected to hinder the market growth. Conversely, the growth of biologics & biosimilars and increase in demand for injectable drugs in prefilled forms offer the lucrative growth opportunities for the market.
The global prefilled syringes market is segmented on the basis of material, design, therapeutic, application, and region. Based on material, the market is categorized into glass-based and plastic-based. By design, it is classified into single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. Depending on therapeutic, it is bifurcated into large molecules and small molecules. Depending on application, it is categorized into anaphylaxis, rheumatoid arthritis, diabetes, and others (cancer, multiple sclerosis and others). Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the prefilled syringes market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By MATERIAL
Glass-based
Plastic-based
By DESIGN
Single-chamber Prefilled Syringes
Dual-chamber Prefilled Syringes
Customized Prefilled Syringes
By THERAPEUTIC
Large Molecules
Small Molecules
By APPLICATION
Anaphylaxis
Rheumatoid Arthritis
Diabetes
Others (Cancer, Multiple Sclerosis, and Others)
By REGION
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia Pacific
Japan
China
Australia
India
South Korea
Rest of Asia Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
Abbott Laboratories
Baxter International
Bayer AG
Becton, Dickinson and Company
Gerresheimer AG
Medtronic PLC
Nipro Corporation
Terumo Medical Corporation
Vetter Pharma International GmbH
West Pharmaceutical Services Inc.
The global prefilled syringes market was valued at $5,620.23 million in 2020, and is projected to reach $15,735.49 million by 2030, registering a CAGR of 10.8% from 2021 to 2030.
A prefilled syringe is a syringe filled with a fixed quantity of a therapeutic drug. These are novel devices used for delivering drugs with improved accuracy, affordability, efficacy, convenience, sterility, safety, and accessibility. These features make it more advantageous than traditional methods of drug delivery where glass or metal vials were used to store pharmaceutical drugs. The removal of drug from these vials was prone to contamination and increased the possibility of dosing errors. Therefore, prefilled syringes eliminate the mentioned drawbacks, resulting in increase in their demand.
The growth in home-based healthcare market, increase in adoption of injectable drugs, rise in incidence rate of chronic diseases, and surge in benefits of using prefilled syringes over conventional vials drive the growth of the market. Moreover, technological advancements related to the prefilled syringes contribute toward the growth of the market. However, stringent government regulations, availability of alternative drug-delivery methods, and product recalls are expected to hinder the market growth. Conversely, the growth of biologics & biosimilars and increase in demand for injectable drugs in prefilled forms offer the lucrative growth opportunities for the market.
The global prefilled syringes market is segmented on the basis of material, design, therapeutic, application, and region. Based on material, the market is categorized into glass-based and plastic-based. By design, it is classified into single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. Depending on therapeutic, it is bifurcated into large molecules and small molecules. Depending on application, it is categorized into anaphylaxis, rheumatoid arthritis, diabetes, and others (cancer, multiple sclerosis and others). Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the prefilled syringes market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By MATERIAL
Glass-based
Plastic-based
By DESIGN
Single-chamber Prefilled Syringes
Dual-chamber Prefilled Syringes
Customized Prefilled Syringes
By THERAPEUTIC
Large Molecules
Small Molecules
By APPLICATION
Anaphylaxis
Rheumatoid Arthritis
Diabetes
Others (Cancer, Multiple Sclerosis, and Others)
By REGION
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia Pacific
Japan
China
Australia
India
South Korea
Rest of Asia Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
Abbott Laboratories
Baxter International
Bayer AG
Becton, Dickinson and Company
Gerresheimer AG
Medtronic PLC
Nipro Corporation
Terumo Medical Corporation
Vetter Pharma International GmbH
West Pharmaceutical Services Inc.
Table of Contents
230 Pages
- CHAPTER 1: INTRODUCTION
- 1.1.Report Description
- 1.2.Key Market Segments
- 1.3.Key Benefits
- 1.4.Research Methodology
- 1.4.1.Primary Research
- 1.4.2.Secondary Research
- 1.4.3.Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1.CXO Perspective
- CHAPTER 3:MARKET LANDSCAPE
- 3.1.Market Definition and Scope
- 3.2.Key Findings
- 3.2.1.Top Investment Pockets
- 3.2.2.Top Winning Strategies
- 3.3.Porter's Five Forces Analysis
- 3.3.1.Bargaining Power of Suppliers
- 3.3.2.Threat of New Entrants
- 3.3.3.Threat of Substitutes
- 3.3.4.Competitive Rivalry
- 3.3.5.Bargaining Power among Buyers
- 3.4.Market Share Analysis/Top Player Positioning
- 3.4.1.Market Share Analysis/Top Player Positioning 2020
- 3.5.Market Dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis
- CHAPTER 4:PREFILLED SYRINGES MARKET, BY MATERIAL
- 4.1.Market Overview
- 4.1.1.Market Size and Forecast, By Material
- 4.2.GLASS-BASED PREFILLED SYRINGES
- 4.2.1.Key Market Trends, Growth Factors and Opportunities
- 4.2.2.Market Size and Forecast, By Region
- 4.2.3.Market Share Analysis, By Country
- 4.3.PLASTIC-BASED PREFILLED SYRINGES
- 4.3.1.Key Market Trends, Growth Factors and Opportunities
- 4.3.2.Market Size and Forecast, By Region
- 4.3.3.Market Share Analysis, By Country
- CHAPTER 5: PREFILLED SYRINGES MARKET, BY DESIGN
- 5.1.Market Overview
- 5.1.1Market Size and Forecast, By Design
- 5.2.SINGLE-CHAMBER PREFILLED SYRINGES
- 5.2.1.Market Size and Forecast, By Region
- 5.2.2.Market Share Analysis, By Country
- 5.3.DUAL-CHAMBER PREFILLED SYRINGES
- 5.3.1.Market Size and Forecast, By Region
- 5.3.2.Market Share Analysis, By Country
- 5.4.CUSTOMIZED PREFILLED SYRINGES
- 5.4.1.Market Size and Forecast, By Region
- 5.4.2.Market Share Analysis, By Country
- CHAPTER 6: PREFILLED SYRINGES MARKET, BY THERAPEUTICS
- 6.1.Market Overview
- 6.1.1Market Size and Forecast, By Therapeutics
- 6.2.LARGE MOLECULES
- 6.2.1.Market Size and Forecast, By Region
- 6.2.2.Market Share Analysis, By Country
- 6.3.SMALL MOLECULES
- 6.3.1.Market Size and Forecast, By Region
- 6.3.2.Market Share Analysis, By Country
- CHAPTER 7:PREFILLED SYRINGES MARKET, BY APPLICATION
- 7.1.Market Overview
- 7.1.1Market Size and Forecast, By Application
- 7.2.ANAPHYLAXIS
- 7.2.1.Market Size and Forecast, By Region
- 7.2.2.Market Share Analysis, By Country
- 7.3.RHEUMATOID ARTHRITIS
- 7.3.1.Market Size and Forecast, By Region
- 7.3.2.Market Share Analysis, By Country
- 7.4.DIABETES
- 7.4.1.Market Size and Forecast, By Region
- 7.4.2.Market Share Analysis, By Country
- 7.5.OTHERS APPLICATIONS
- 7.5.1.Market Size and Forecast, By Region
- 7.5.2.Market Share Analysis, By Country
- CHAPTER 8:PREFILLED SYRINGES MARKET, BY REGION
- 8.1.Market Overview
- 8.1.1Market Size and Forecast, By Region
- 8.2.North America
- 8.2.1.Key Market Trends and Opportunities
- 8.2.2.Market Size and Forecast, By Material
- 8.2.3.Market Size and Forecast, By Design
- 8.2.4.Market Size and Forecast, By Therapeutics
- 8.2.5.Market Size and Forecast, By Application
- 8.2.6.Market Size and Forecast, By Country
- 8.2.7.United States Prefilled Syringes Market
- 8.2.7.1.Market Size and Forecast, By Material
- 8.2.7.2.Market Size and Forecast, By Design
- 8.2.7.3.Market Size and Forecast, By Therapeutics
- 8.2.7.4.Market Size and Forecast, By Application
- 8.2.8.Canada Prefilled Syringes Market
- 8.2.8.1.Market Size and Forecast, By Material
- 8.2.8.2.Market Size and Forecast, By Design
- 8.2.8.3.Market Size and Forecast, By Therapeutics
- 8.2.8.4.Market Size and Forecast, By Application
- 8.2.9.Mexico Prefilled Syringes Market
- 8.2.9.1.Market Size and Forecast, By Material
- 8.2.9.2.Market Size and Forecast, By Design
- 8.2.9.3.Market Size and Forecast, By Therapeutics
- 8.2.9.4.Market Size and Forecast, By Application
- 8.3.Europe
- 8.3.1.Key Market Trends and Opportunities
- 8.3.2.Market Size and Forecast, By Material
- 8.3.3.Market Size and Forecast, By Design
- 8.3.4.Market Size and Forecast, By Therapeutics
- 8.3.5.Market Size and Forecast, By Application
- 8.3.6.Market Size and Forecast, By Country
- 8.3.7.Germany Prefilled Syringes Market
- 8.3.7.1.Market Size and Forecast, By Material
- 8.3.7.2.Market Size and Forecast, By Design
- 8.3.7.3.Market Size and Forecast, By Therapeutics
- 8.3.7.4.Market Size and Forecast, By Application
- 8.3.8.France Prefilled Syringes Market
- 8.3.8.1.Market Size and Forecast, By Material
- 8.3.8.2.Market Size and Forecast, By Design
- 8.3.8.3.Market Size and Forecast, By Therapeutics
- 8.3.8.4.Market Size and Forecast, By Application
- 8.3.9.Uk Prefilled Syringes Market
- 8.3.9.1.Market Size and Forecast, By Material
- 8.3.9.2.Market Size and Forecast, By Design
- 8.3.9.3.Market Size and Forecast, By Therapeutics
- 8.3.9.4.Market Size and Forecast, By Application
- 8.3.10.Italy Prefilled Syringes Market
- 8.3.10.1.Market Size and Forecast, By Material
- 8.3.10.2.Market Size and Forecast, By Design
- 8.3.10.3.Market Size and Forecast, By Therapeutics
- 8.3.10.4.Market Size and Forecast, By Application
- 8.3.11.Spain Prefilled Syringes Market
- 8.3.11.1.Market Size and Forecast, By Material
- 8.3.11.2.Market Size and Forecast, By Design
- 8.3.11.3.Market Size and Forecast, By Therapeutics
- 8.3.11.4.Market Size and Forecast, By Application
- 8.3.12.Rest Of Europe Prefilled Syringes Market
- 8.3.12.1.Market Size and Forecast, By Material
- 8.3.12.2.Market Size and Forecast, By Design
- 8.3.12.3.Market Size and Forecast, By Therapeutics
- 8.3.12.4.Market Size and Forecast, By Application
- 8.4.Asia-Pacific
- 8.4.1.Key Market Trends and Opportunities
- 8.4.2.Market Size and Forecast, By Material
- 8.4.3.Market Size and Forecast, By Design
- 8.4.4.Market Size and Forecast, By Therapeutics
- 8.4.5.Market Size and Forecast, By Application
- 8.4.6.Market Size and Forecast, By Country
- 8.4.7.China Prefilled Syringes Market
- 8.4.7.1.Market Size and Forecast, By Material
- 8.4.7.2.Market Size and Forecast, By Design
- 8.4.7.3.Market Size and Forecast, By Therapeutics
- 8.4.7.4.Market Size and Forecast, By Application
- 8.4.8.Japan Prefilled Syringes Market
- 8.4.8.1.Market Size and Forecast, By Material
- 8.4.8.2.Market Size and Forecast, By Design
- 8.4.8.3.Market Size and Forecast, By Therapeutics
- 8.4.8.4.Market Size and Forecast, By Application
- 8.4.9.India Prefilled Syringes Market
- 8.4.9.1.Market Size and Forecast, By Material
- 8.4.9.2.Market Size and Forecast, By Design
- 8.4.9.3.Market Size and Forecast, By Therapeutics
- 8.4.9.4.Market Size and Forecast, By Application
- 8.4.10.Australia Prefilled Syringes Market
- 8.4.10.1.Market Size and Forecast, By Material
- 8.4.10.2.Market Size and Forecast, By Design
- 8.4.10.3.Market Size and Forecast, By Therapeutics
- 8.4.10.4.Market Size and Forecast, By Application
- 8.4.11.South Korea Prefilled Syringes Market
- 8.4.11.1.Market Size and Forecast, By Material
- 8.4.11.2.Market Size and Forecast, By Design
- 8.4.11.3.Market Size and Forecast, By Therapeutics
- 8.4.11.4.Market Size and Forecast, By Application
- 8.4.12.Rest Of Asia-pacific Prefilled Syringes Market
- 8.4.12.1.Market Size and Forecast, By Material
- 8.4.12.2.Market Size and Forecast, By Design
- 8.4.12.3.Market Size and Forecast, By Therapeutics
- 8.4.12.4.Market Size and Forecast, By Application
- 8.5.LAMEA
- 8.5.1.Key Market Trends and Opportunities
- 8.5.2.Market Size and Forecast, By Material
- 8.5.3.Market Size and Forecast, By Design
- 8.5.4.Market Size and Forecast, By Therapeutics
- 8.5.5.Market Size and Forecast, By Application
- 8.5.6.Market Size and Forecast, By Country
- 8.5.7.Brazil Prefilled Syringes Market
- 8.5.7.1.Market Size and Forecast, By Material
- 8.5.7.2.Market Size and Forecast, By Design
- 8.5.7.3.Market Size and Forecast, By Therapeutics
- 8.5.7.4.Market Size and Forecast, By Application
- 8.5.8.South Africa, Prefilled Syringes Market
- 8.5.8.1.Market Size and Forecast, By Material
- 8.5.8.2.Market Size and Forecast, By Design
- 8.5.8.3.Market Size and Forecast, By Therapeutics
- 8.5.8.4.Market Size and Forecast, By Application
- 8.5.9.Saudi Arabia Prefilled Syringes Market
- 8.5.9.1.Market Size and Forecast, By Material
- 8.5.9.2.Market Size and Forecast, By Design
- 8.5.9.3.Market Size and Forecast, By Therapeutics
- 8.5.9.4.Market Size and Forecast, By Application
- 8.5.10.Rest of LAMEA Prefilled Syringes Market
- 8.5.10.1.Market Size and Forecast, By Material
- 8.5.10.2.Market Size and Forecast, By Design
- 8.5.10.3.Market Size and Forecast, By Therapeutics
- 8.5.10.4.Market Size and Forecast, By Application
- CHAPTER 9: COMPANY PROFILES
- 9.1.ABBOTT LABORATORIES
- 9.1.1.Company Overview
- 9.1.2.Key Executives
- 9.1.3.Company snapshot
- 9.1.4.Operating business segments
- 9.1.5.Product portfolio
- 9.1.6.Business Performance
- 9.1.7.Key Strategic Moves and Developments
- 9.2.BAYER AG
- 9.2.1.Company Overview
- 9.2.2.Key Executives
- 9.2.3.Company snapshot
- 9.2.4.Operating business segments
- 9.2.5.Product portfolio
- 9.2.6.Business Performance
- 9.2.7.Key Strategic Moves and Developments
- 9.3.BAXTER INTERNATIONAL
- 9.3.1.Company Overview
- 9.3.2.Key Executives
- 9.3.3.Company snapshot
- 9.3.4.Operating business segments
- 9.3.5.Product portfolio
- 9.3.6.Business Performance
- 9.3.7.Key Strategic Moves and Developments
- 9.4.BECTON, DICKINSON AND COMPANY
- 9.4.1.Company Overview
- 9.4.2.Key Executives
- 9.4.3.Company snapshot
- 9.4.4.Operating business segments
- 9.4.5.Product portfolio
- 9.4.6.Business Performance
- 9.4.7.Key Strategic Moves and Developments
- 9.5.GERRESHEIMER AG
- 9.5.1.Company Overview
- 9.5.2.Key Executives
- 9.5.3.Company snapshot
- 9.5.4.Operating business segments
- 9.5.5.Product portfolio
- 9.5.6.Business Performance
- 9.5.7.Key Strategic Moves and Developments
- 9.6.MEDTRONIC PLC
- 9.6.1.Company Overview
- 9.6.2.Key Executives
- 9.6.3.Company snapshot
- 9.6.4.Operating business segments
- 9.6.5.Product portfolio
- 9.6.6.Business Performance
- 9.6.7.Key Strategic Moves and Developments
- 9.7.NIPRO CORPORATION
- 9.7.1.Company Overview
- 9.7.2.Key Executives
- 9.7.3.Company snapshot
- 9.7.4.Operating business segments
- 9.7.5.Product portfolio
- 9.7.6.Business Performance
- 9.7.7.Key Strategic Moves and Developments
- 9.8.TERUMO MEDICAL CORPORATION
- 9.8.1.Company Overview
- 9.8.2.Key Executives
- 9.8.3.Company snapshot
- 9.8.4.Operating business segments
- 9.8.5.Product portfolio
- 9.8.6.Business Performance
- 9.8.7.Key Strategic Moves and Developments
- 9.9.VETTER PHARMA INTERNATIONAL GMBH
- 9.9.1.Company Overview
- 9.9.2.Key Executives
- 9.9.3.Company snapshot
- 9.9.4.Operating business segments
- 9.9.5.Product portfolio
- 9.9.6.Business Performance
- 9.9.7.Key Strategic Moves and Developments
- 9.10.WEST PHARMACEUTICAL SERVICES, INC.
- 9.10.1.Company Overview
- 9.10.2.Key Executives
- 9.10.3.Company snapshot
- 9.10.4.Operating business segments
- 9.10.5.Product portfolio
- 9.10.6.Business Performance
- 9.10.7.Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1.GLOBAL PREFILLED SYRINGES MARKET, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 2.GLOBAL PREFILLED SYRINGES MARKET FOR GLASS-BASED PREFILLED SYRINGES, BY REGION, 2020-2030 ($MILLION)
- TABLE 3.GLOBAL PREFILLED SYRINGES MARKET FOR PLASTIC-BASED PREFILLED SYRINGES, BY REGION, 2020-2030 ($MILLION)
- TABLE 4.GLOBAL PREFILLED SYRINGES MARKET, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 5.GLOBAL PREFILLED SYRINGES MARKET FOR SINGLE-CHAMBER PREFILLED SYRINGES, BY REGION, 2020-2030 ($MILLION)
- TABLE 6.GLOBAL PREFILLED SYRINGES MARKET FOR DUAL-CHAMBER PREFILLED SYRINGES, BY REGION, 2020-2030 ($MILLION)
- TABLE 7.GLOBAL PREFILLED SYRINGES MARKET FOR CUSTOMIZED PREFILLED SYRINGES, BY REGION, 2020-2030 ($MILLION)
- TABLE 8.GLOBAL PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 9.GLOBAL PREFILLED SYRINGES MARKET FOR LARGE MOLECULES, BY REGION, 2020-2030 ($MILLION)
- TABLE 10.GLOBAL PREFILLED SYRINGES MARKET FOR SMALL MOLECULES, BY REGION, 2020-2030 ($MILLION)
- TABLE 11.GLOBAL PREFILLED SYRINGES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 12.GLOBAL PREFILLED SYRINGES MARKET FOR ANAPHYLAXIS, BY REGION, 2020-2030 ($MILLION)
- TABLE 13.GLOBAL PREFILLED SYRINGES MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2020-2030 ($MILLION)
- TABLE 14.GLOBAL PREFILLED SYRINGES MARKET FOR DIABETES, BY REGION, 2020-2030 ($MILLION)
- TABLE 15.GLOBAL PREFILLED SYRINGES MARKET FOR OTHERS APPLICATIONS, BY REGION, 2020-2030 ($MILLION)
- TABLE 16.GLOBAL PREFILLED SYRINGES MARKET, BY REGION, 2020-2030 ($MILLION)
- TABLE 17.NORTH AMERICA PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 18.NORTH AMERICA PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 19.NORTH AMERICA PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 20.NORTH AMERICA PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 21.UNITED STATES PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 22.UNITED STATES PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 23.UNITED STATES PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 24.UNITED STATES PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 25.CANADA PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 26.CANADA PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 27.CANADA PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 28.CANADA PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 29.MEXICO PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 30.MEXICO PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 31.MEXICO PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 32.MEXICO PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 33.EUROPE PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 34.EUROPE PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 35.EUROPE PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 36.EUROPE PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 37.GERMANY PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 38.GERMANY PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 39.GERMANY PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 40.GERMANY PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 41.FRANCE PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 42.FRANCE PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 43.FRANCE PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 44.FRANCE PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 45.UK PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 46.UK PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 47.UK PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 48.UK PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 49.ITALY PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 50.ITALY PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 51.ITALY PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 52.ITALY PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 53.SPAIN PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 54.SPAIN PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 55.SPAIN PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 56.SPAIN PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 57.REST OF EUROPE PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 58.REST OF EUROPE PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 59.REST OF EUROPE PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 60.REST OF EUROPE PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 61.ASIA-PACIFIC PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 62.ASIA-PACIFIC PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 63.ASIA-PACIFIC PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 64.ASIA-PACIFIC PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 65.CHINA PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 66.CHINA PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 67.CHINA PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 68.CHINA PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 69.JAPAN PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 70.JAPAN PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 71.JAPAN PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 72.JAPAN PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 73.INDIA PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 74.INDIA PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 75.INDIA PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 76.INDIA PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 77.AUSTRALIA PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 78.AUSTRALIA PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 79.AUSTRALIA PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 80.AUSTRALIA PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 81.SOUTH KOREA PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 82.SOUTH KOREA PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 83.SOUTH KOREA PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 84.SOUTH KOREA PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 85.REST OF ASIA-PACIFIC PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 86.REST OF ASIA-PACIFIC PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 87.REST OF ASIA-PACIFIC PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 88.REST OF ASIA-PACIFIC PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 89.LAMEA PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 90.LAMEA PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 91.LAMEA PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 92.LAMEA PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 93.BRAZIL PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 94.BRAZIL PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 95.BRAZIL PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 96.BRAZIL PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 97.SOUTH AFRICA, PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 98.SOUTH AFRICA, PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 99.SOUTH AFRICA, PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 100.SOUTH AFRICA, PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 101.SAUDI ARABIA PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 102.SAUDI ARABIA PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 103.SAUDI ARABIA PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 104.SAUDI ARABIA PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 105.REST OF LAMEA PREFILLED SYRINGES, BY MATERIAL, 2020-2030 ($MILLION)
- TABLE 106.REST OF LAMEA PREFILLED SYRINGES, BY DESIGN, 2020-2030 ($MILLION)
- TABLE 107.REST OF LAMEA PREFILLED SYRINGES, BY THERAPEUTICS, 2020-2030 ($MILLION)
- TABLE 108.REST OF LAMEA PREFILLED SYRINGES, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 109.ABBOTT LABORATORIES: KEY EXECUTIVES
- TABLE 110.ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 111.ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 112.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 113.ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 114.BAYER AG: KEY EXECUTIVES
- TABLE 115.BAYER AG: COMPANY SNAPSHOT
- TABLE 116.BAYER AG: OPERATING SEGMENTS
- TABLE 117.BAYER AG: PRODUCT PORTFOLIO
- TABLE 118.BAYER AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 119.BAXTER INTERNATIONAL: KEY EXECUTIVES
- TABLE 120.BAXTER INTERNATIONAL: COMPANY SNAPSHOT
- TABLE 121.BAXTER INTERNATIONAL: OPERATING SEGMENTS
- TABLE 122.BAXTER INTERNATIONAL: PRODUCT PORTFOLIO
- TABLE 123.BAXTER INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 124.BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
- TABLE 125.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- TABLE 126.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
- TABLE 127.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
- TABLE 128.BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 129.GERRESHEIMER AG: KEY EXECUTIVES
- TABLE 130.GERRESHEIMER AG: COMPANY SNAPSHOT
- TABLE 131.GERRESHEIMER AG: OPERATING SEGMENTS
- TABLE 132.GERRESHEIMER AG: PRODUCT PORTFOLIO
- TABLE 133.GERRESHEIMER AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 134.MEDTRONIC PLC: KEY EXECUTIVES
- TABLE 135.MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 136.MEDTRONIC PLC: OPERATING SEGMENTS
- TABLE 137.MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 138.MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 139.NIPRO CORPORATION: KEY EXECUTIVES
- TABLE 140.NIPRO CORPORATION: COMPANY SNAPSHOT
- TABLE 141.NIPRO CORPORATION: OPERATING SEGMENTS
- TABLE 142.NIPRO CORPORATION: PRODUCT PORTFOLIO
- TABLE 143.NIPRO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 144.TERUMO MEDICAL CORPORATION: KEY EXECUTIVES
- TABLE 145.TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
- TABLE 146.TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
- TABLE 147.TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO
- TABLE 148.TERUMO MEDICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 149.VETTER PHARMA INTERNATIONAL GMBH: KEY EXECUTIVES
- TABLE 150.VETTER PHARMA INTERNATIONAL GMBH: COMPANY SNAPSHOT
- TABLE 151.VETTER PHARMA INTERNATIONAL GMBH: OPERATING SEGMENTS
- TABLE 152.VETTER PHARMA INTERNATIONAL GMBH: PRODUCT PORTFOLIO
- TABLE 153.VETTER PHARMA INTERNATIONAL GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 154.WEST PHARMACEUTICAL SERVICES, INC.: KEY EXECUTIVES
- TABLE 155.WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT
- TABLE 156.WEST PHARMACEUTICAL SERVICES, INC.: OPERATING SEGMENTS
- TABLE 157.WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT PORTFOLIO
- TABLE 158.WEST PHARMACEUTICAL SERVICES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1.GLOBAL PREFILLED SYRINGES MARKET SEGMENTATION
- FIGURE 2.GLOBAL PREFILLED SYRINGES MARKET
- FIGURE 3.SEGMENTATION PREFILLED SYRINGES MARKET
- FIGURE 4.TOP INVESTMENT POCKET IN PREFILLED SYRINGES MARKET
- FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
- FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
- FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
- FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
- FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
- FIGURE 11.LOW THREAT OF SUBSTITUTION
- FIGURE 12.HIGH COMPETITIVE RIVALRY
- FIGURE 13.TOP PLAYER POSITIONING, 2020
- FIGURE 14.MARKET SHARE ANALYSIS, 2020
- FIGURE 15.RESTRAINTS AND DRIVERS: PREFILLED SYRINGES MARKET
- FIGURE 16.PREFILLED SYRINGES MARKET SEGMENTATION, BY MATERIAL
- FIGURE 17.PREFILLED SYRINGES MARKET FOR GLASS-BASED PREFILLED SYRINGES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 18.PREFILLED SYRINGES MARKET FOR PLASTIC-BASED PREFILLED SYRINGES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 19.PREFILLED SYRINGES MARKET SEGMENTATION, BY DESIGN
- FIGURE 20.PREFILLED SYRINGES MARKET FOR SINGLE-CHAMBER PREFILLED SYRINGES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 21.PREFILLED SYRINGES MARKET FOR DUAL-CHAMBER PREFILLED SYRINGES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 22.PREFILLED SYRINGES MARKET FOR CUSTOMIZED PREFILLED SYRINGES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 23.PREFILLED SYRINGES MARKET SEGMENTATION, BY THERAPEUTICS
- FIGURE 24.PREFILLED SYRINGES MARKET FOR LARGE MOLECULES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 25.PREFILLED SYRINGES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 26.PREFILLED SYRINGES MARKET SEGMENTATION, BY APPLICATION
- FIGURE 27.PREFILLED SYRINGES MARKET FOR ANAPHYLAXIS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 28.PREFILLED SYRINGES MARKET FOR RHEUMATOID ARTHRITIS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 29.PREFILLED SYRINGES MARKET FOR DIABETES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 30.PREFILLED SYRINGES MARKET FOR OTHERS APPLICATIONS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 31.ABBOTT LABORATORIES: NET SALES, 2018-2020 ($MILLION)
- FIGURE 32.ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 33.ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 34.BAYER AG: NET SALES, 2018-2020 ($MILLION)
- FIGURE 35.BAYER AG: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 36.BAYER AG: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 37.BAXTER INTERNATIONAL: NET SALES, 2018-2020 ($MILLION)
- FIGURE 38.BAXTER INTERNATIONAL: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 39.BAXTER INTERNATIONAL: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 40.BECTON, DICKINSON AND COMPANY: NET SALES, 2018-2020 ($MILLION)
- FIGURE 41.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 42.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 43.GERRESHEIMER AG: NET SALES, 2018-2020 ($MILLION)
- FIGURE 44.GERRESHEIMER AG: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 45.GERRESHEIMER AG: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 46.MEDTRONIC PLC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 47.MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 48.MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 49.NIPRO CORPORATION: NET SALES, 2018-2020 ($MILLION)
- FIGURE 50.NIPRO CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 51.NIPRO CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 52.TERUMO MEDICAL CORPORATION: NET SALES, 2018-2020 ($MILLION)
- FIGURE 53.TERUMO MEDICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 54.TERUMO MEDICAL CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 55.VETTER PHARMA INTERNATIONAL GMBH: NET SALES, 2018-2020 ($MILLION)
- FIGURE 56.VETTER PHARMA INTERNATIONAL GMBH: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 57.VETTER PHARMA INTERNATIONAL GMBH: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 58.WEST PHARMACEUTICAL SERVICES, INC.: NET SALES, 2018-2020 ($MILLION)
- FIGURE 59.WEST PHARMACEUTICAL SERVICES, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 60.WEST PHARMACEUTICAL SERVICES, INC.: REVENUE SHARE, BY REGION, 2020 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
